Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
| Stock | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| WGSGeneDx Holdings Corp. | Eli CasdinDirector, 10% Owner | $21.5M | Added | |||
| Casdin Partners Master Fund bought 500K shares across May 18–20 at wtd-avg ~$42.92 (range $42.46–$43.81). Post-buy spot $47.33 (+10.3%). Director and 10% owner of the genomic-testing platform; fund now holds 3.51M shares. High-conviction buy cluster coinciding with strong Q1 earnings momentum. | ||||||
| FBINFortune Brands Innovations, Inc. | Edward P. GardenDirector | $13.7M | Added | |||
| 403K shares May 19 at $33.40 avg ($32.34–$33.83) + 5,900 shares May 20 at $33.28 avg; bought near 52-wk low with stock ~30% off YTD highs amid CEO search. Post-buy spot $36.05 (+8.0%). Indirect holding via GI SPV II L.P. and Green 73 LLC. Combined with second Form 4, Garden controls ~3.62M shares. | ||||||
| FBINFortune Brands Innovations, Inc. | Edward P. GardenDirector | $2.00M | Added | |||
| Separate Form 4 block: 57,400 shares at $34.89 avg ($34.56–$35.00) on May 20 via different Garden-affiliated entities. Post-buy spot $36.05 (+3.3%). Second same-week filing reinforces Garden's conviction as FBIN begins to recover from lows. | ||||||
| TXOTXO Partners, L.P. | Bob R. SimpsonDirector, 10% Owner | $1.97M | Added | |||
| 58,251 units May 18 at $13.17 avg + 90,152 units May 20 at $13.35 avg. Builds on a May 15 purchase of 64K units. Simpson now directly holds 7.95M units; repeat-buyer pattern in this nat-gas-weighted MLP. Post-buy spot $13.75 (+3.5%). | ||||||
| MPMP Materials Corp. | Michael Stuart RosenthalCOO | $963K | Added | |||
| Bought 17,000 shares May 20 at $56.62 avg. COO already holds 1.33M shares directly + 126K via Rosenthal Family Trust. Rare-earth supply-chain story with U.S. policy tailwinds. Post-buy spot $61.74 (+9.0%). | ||||||
| AMRZAmrize Ltd | Jan Philipp JenischChairman & CEO | $938K | Added | |||
| 19,001 shares at ~$49.39 avg ($48.50–$49.96) across 7 transactions May 19 (incl. 3K indirect via spouse). 11th buy in 6 months; ~107K total shares acquired by CEO. Amrize is the NYSE-listed Holcim Americas spinoff. Post-buy spot $50.49 (+2.2%). | ||||||
Scanned the last 24 hours of EDGAR Form 4 filings (transactions May 19–21, filed May 20–22). 6 qualifying buys (≥ $250K, transaction type P) totalling $41.0M.
All 6 insiders are currently in the green. The scan skews toward industrials, materials, and healthcare — sectors hit hard YTD that are now attracting conviction buyers at or near multi-year lows.
WGS (GeneDx) is the standout: Casdin Partners' $21.5M purchase in three days is the largest single insider buy in the batch. Casdin Capital is a specialist healthcare fund and Eli Casdin sits on the GeneDx board — this is a high-signal buy in a genomic testing platform that just reported earnings. The stock's +10% reaction since the buy date confirms the market is on board.
FBIN (Fortune Brands Innovations) is the most contrarian story: Edward Garden stepped in with ~$15.7M as the stock sat ~30% off its 52-week high amid a CEO search and board reshuffling. Garden now indirectly controls 3.62M shares. FBIN was near its 52-week low of $32.34 when he bought; it has bounced +8% since.
MP Materials (MP) sees COO Rosenthal reloading with a $963K open-market buy, adding to his already substantial 1.33M-share direct stake. The rare-earth sector has been a focus of U.S. policy, and this buy comes shortly after the company's 8-K updates.
Amrize (AMRZ) CEO Jenisch has now bought shares 11 times in the last 6 months, totaling ~107K shares. His persistent buying in the newly listed building-materials spinoff signals long-term confidence in the post-Holcim Americas thesis.
TXO Partners (TXO) director Bob Simpson continues a pattern of accumulation in the natural gas–weighted MLP, now holding 7.95M units directly. His repeated buys signal comfort with energy distribution fundamentals.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.